Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Jun 2024 for Biora Therapeutics, INC.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Lynne Powell: trading record in brief
Lynne Powell (board member) discloses dealings in 2 companies, chiefly Biora Therapeutics, Inc. and Biocryst Pharmaceuticals Inc. In total, 6 filings cover trades dated from 26 January 2016 to 5 June 2024.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 6 June 2024 with a share grant in Biora Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Lynne Powell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
12,500 shares0Common StockSEC:0000950170-24-069929:0
12,500 shares0Common StockSEC:0000950170-23-028596:0
45 sharesSeries X Preferred StockSEC:0000899243-23-000960:0
96,154 shares0Common StockSEC:0000899243-22-023090:0
29,183 shares0Common StockSEC:0000899243-21-024210:0
3,850 sharesCommon StockSEC:0001127602-16-038015:0
6 of 6 declarations
